Benzinga | Apr 29, 2021 08:24AM EDT

Morgan Stanley Maintains Underweight on NOV, Raises Price Target to $13

Morgan Stanley maintains NOV (NYSE:NOV) with a Underweight and raises the price target from $12 to $13.